BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 22138618)

  • 1. Reduction of misleading ("false") positive results in mammalian cell genotoxicity assays. I. Choice of cell type.
    Fowler P; Smith K; Young J; Jeffrey L; Kirkland D; Pfuhler S; Carmichael P
    Mutat Res; 2012 Feb; 742(1-2):11-25. PubMed ID: 22138618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between p53 status, apoptosis and induction of micronuclei in different human and mouse cell lines in vitro: Implications for improving existing assays.
    Whitwell J; Smith R; Jenner K; Lyon H; Wood D; Clements J; Aschcroft-Hawley K; Gollapudi B; Kirkland D; Lorge E; Pfuhler S; Tanir JY; Thybaud V
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Aug; 789-790():7-27. PubMed ID: 26232254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of p53 function in different magnitude of genotoxic and cytotoxic responses in in vitro micronucleus assays.
    Hashimoto K; Nakajima Y; Uematsu R; Matsumura S; Chatani F
    Mutat Res; 2011 Nov; 726(1):21-8. PubMed ID: 21855649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
    Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
    Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of in vitro micronucleus and gene mutation assay results for p53-competent versus p53-deficient human lymphoblastoid cells.
    Honma M; Hayashi M
    Environ Mol Mutagen; 2011 Jun; 52(5):373-84. PubMed ID: 20963812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of misleading ("false") positive results in mammalian cell genotoxicity assays. II. Importance of accurate toxicity measurement.
    Fowler P; Smith R; Smith K; Young J; Jeffrey L; Kirkland D; Pfuhler S; Carmichael P
    Mutat Res; 2012 Aug; 747(1):104-117. PubMed ID: 22595317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of micronuclei and DNA damage induced by Ochratoxin A in two mammalian cell lines.
    Ali R; Mittelstaedt RA; Shaddock JG; Ding W; Bhalli JA; Khan QM; Heflich RH
    Mutat Res; 2011 Jul; 723(1):58-64. PubMed ID: 21554981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.
    Kirkland D; Reeve L; Gatehouse D; Vanparys P
    Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of reducing the top concentration used in the in vitro chromosomal aberration test in CHL cells on the evaluation of industrial chemical genotoxicity.
    Morita T; Honma M; Morikawa K
    Mutat Res; 2012 Jan; 741(1-2):32-56. PubMed ID: 22020093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of in vivo genotoxicity assessment: combination of acute tests and integration into standard toxicity testing.
    Rothfuss A; Honma M; Czich A; Aardema MJ; Burlinson B; Galloway S; Hamada S; Kirkland D; Heflich RH; Howe J; Nakajima M; O'Donovan M; Plappert-Helbig U; Priestley C; Recio L; Schuler M; Uno Y; Martus HJ
    Mutat Res; 2011 Aug; 723(2):108-20. PubMed ID: 21182982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome aberrations in vitro related to cytotoxicity of nonmutagenic chemicals and metabolic poisons.
    Hilliard CA; Armstrong MJ; Bradt CI; Hill RB; Greenwood SK; Galloway SM
    Environ Mol Mutagen; 1998; 31(4):316-26. PubMed ID: 9654240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The micronucleus test and NTP rodent carcinogens: not so many false negatives.
    Galloway SM
    Mutat Res; 1996 Jun; 352(1-2):185-8. PubMed ID: 8676909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of misleading ("false") positive results in mammalian cell genotoxicity assays. III: sensitivity of human cell types to known genotoxic agents.
    Fowler P; Smith R; Smith K; Young J; Jeffrey L; Carmichael P; Kirkland D; Pfuhler S
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Jun; 767():28-36. PubMed ID: 24632063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of four different treatment conditions of extended exposure in the in vitro micronucleus assay using TK6 lymphoblastoid cells.
    Hashimoto K; Nakajima Y; Matsumura S; Chatani F
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):28-36. PubMed ID: 20800082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaborative study on fifteen compounds in the rat-liver Comet assay integrated into 2- and 4-week repeat-dose studies.
    Rothfuss A; O'Donovan M; De Boeck M; Brault D; Czich A; Custer L; Hamada S; Plappert-Helbig U; Hayashi M; Howe J; Kraynak AR; van der Leede BJ; Nakajima M; Priestley C; Thybaud V; Saigo K; Sawant S; Shi J; Storer R; Struwe M; Vock E; Galloway S
    Mutat Res; 2010 Sep; 702(1):40-69. PubMed ID: 20656055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome aberrations in Chinese hamster and human cells: a comparison using compounds with various genotoxicity profiles.
    Hilliard C; Hill R; Armstrong M; Fleckenstein C; Crowley J; Freeland E; Duffy D; Galloway SM
    Mutat Res; 2007 Mar; 616(1-2):103-18. PubMed ID: 17174355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of published data for top concentration considerations in mammalian cell genotoxicity testing.
    Parry JM; Parry E; Phrakonkham P; Corvi R
    Mutagenesis; 2010 Nov; 25(6):531-8. PubMed ID: 20720196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.